Literature DB >> 9466642

Are physicians' office laboratory results of comparable quality to those produced in other laboratory settings?

J Hurst1, K Nickel, L H Hilborne.   

Abstract

CONTEXT: In 1995, California adopted a bill that brought laboratory laws in line with the 1988 Clinical Laboratory Improvement Amendments' standards for clinical laboratories and mandated a study comparing results in physicians' office laboratories (POLs) with other settings.
OBJECTIVE: To determine whether persons conducting tests in POLs produce accurate and reliable test results comparable to those produced by non-POLs.
DESIGN: Survey of clinical laboratories using proficiency testing data.
SETTING: All California clinical laboratories participating in the American Association of Bioanalysts proficiency testing program in 1996 (n=1110). MAIN OUTCOME MEASURES: "Unsatisfactory" (single testing event failure) and "unsuccessful" (repeated testing event failure) on proficiency testing samples.
RESULTS: The unsatisfactory failure rate for POLs was nearly 3 times (21.5% vs 8.1%) the rate for the non-POLs and about 1.5 times (21.5% vs 14.0%) for POLs that used laboratory professionals as testing or supervisory personnel (P<.001). The POL unsuccessful rate was more than 4 times (4.4% vs 0.9%) the rate for non-POLs and more than twice (4.4% vs 1.8%) the rate for the POLs using laboratory professionals (P<.001).
CONCLUSIONS: Significant differences exist among POLs, POLs using licensed clinical laboratory scientists (medical technologists), and non-POLs. Testing personnel in many POLs might lack the necessary education, training, and oversight common to larger facilities. We must better understand the contributing factors that result in the poorer results of POLs relative to non-POLs. In the meantime, patients should be aware that preliminary findings suggest that differences in quality of laboratory tests based on testing site may exist. Laboratory directors at all testing sites must ensure that they understand laboratory practice sufficiently to minimize errors and maximize accuracy and reliability. Directors must understand their obligation when they elect to oversee those assigned testing responsibility. Legislators may wish to reconsider the wisdom of further easing restrictions on those to whom we entrust our laboratory specimens.

Entities:  

Mesh:

Year:  1998        PMID: 9466642     DOI: 10.1001/jama.279.6.468

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Evaluation of mycology laboratory proficiency testing.

Authors:  A A Reilly; I F Salkin; M R McGinnis; S Gromadzki; L Pasarell; M Kemna; N Higgins; M Salfinger
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Wrong biochemistry results. Companies and Medical Devices Agency must act to prevent wrong results.

Authors:  Ian D Watson; K Lawton
Journal:  BMJ       Date:  2002-02-16

3.  Evaluation of test results of microbiology laboratories of North India for standard tests for syphilis under an external quality assurance scheme.

Authors:  S M Gupta; M Bala; S Muralidhar; K Ray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-01       Impact factor: 3.267

4.  Retrospective analysis of 55,769 HbA1c EQA results obtained from professional laboratories and medical offices participating in surveys organized by two European EQA centers over a nine-year period.

Authors:  Pierre-Alain Morandi; André Deom; Dagmar Kesseler; Richard Cohen
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

5.  Evaluation of analytical errors in a clinical chemistry laboratory: a 3 year experience.

Authors:  As Sakyi; Ef Laing; Rk Ephraim; Of Asibey; Ok Sadique
Journal:  Ann Med Health Sci Res       Date:  2015 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.